We are dedicated to transforming the treatment of inflammatory-mediated musculoskeletal conditions and degenerative arthritis through the development of novel therapeutics and proprietary biomarker platforms, offering scalable solutions for early intervention, disease monitoring, and improved patient outcomes in an underserved market.